New products

Shimadzu Diagnostics launches cell and IL-6 kits for monocyte activation testing

The aMylc cell and dedicated IL-6 ELISA kits support laboratories evaluating a pyrogen-test alternative described in the Japanese Pharmacopoeia's reference information.

On 11 November 2026, Shimadzu Diagnostics announced the Japanese launch of its MylcMAT Cell kit and PyroFinder MAT IL-6 assay kit for the monocyte activation test (MAT). The product codes are 69259 and 69271, respectively. The company specifies storage at −70°C or below for the cell kit and 2–8°C for the IL-6 kit. No transition period is stated for this product launch.

Illustration for Shimadzu Diagnostics launches cell and IL-6 kits for monocyte activation testing

The combination uses the aMylc immortalized human peripheral-blood monocyte-derived cells developed by MiCAN Technologies and measures their response through a dedicated IL-6 ELISA kit. MAT is used to detect pyrogens. The nineteenth edition of the Japanese Pharmacopoeia includes reference information on MAT, G4-13-190. This product launch does not itself amend the Pharmacopoeia or require a universal replacement of rabbit pyrogen testing for every product.

Quality-control laboratories considering the kits should assess suitability for their product and sample matrix, test validity criteria, interference and recovery, positive and negative controls, and interpretation of the IL-6 response against the Pharmacopoeia and product documentation. The announcement gives no universal decision threshold or product-specific validation data, so kit availability alone does not establish equivalence to an existing test.